{"disease":{"id":"antipsychotic-agents","name":"antipsychotic agents"},"drugs":{"marketed":[],"pipeline":[],"offLabel":[],"totalMarketed":0,"totalPipeline":0},"trials":{"data":[{"nct_id":"NCT04922593","title":"Relative Bioavailability of LY03010 Compared to Listed Drug","phase":"PHASE1","overall_status":"COMPLETED","enrollment_count":281,"lead_sponsor_name":"Luye Pharma Group Ltd.","has_results":false},{"nct_id":"NCT05766007","title":"Long-acting Injectable Antipsychotics for Mental Ill-Health in Pregnancy and Postpartum","phase":"","overall_status":"COMPLETED","enrollment_count":168,"lead_sponsor_name":"University of Liverpool","has_results":false},{"nct_id":"NCT04478838","title":"\"Extended\" (Alternate Day) Antipsychotic Dosing","phase":"PHASE4","overall_status":"RECRUITING","enrollment_count":120,"lead_sponsor_name":"Centre for Addiction and Mental Health","has_results":false},{"nct_id":"NCT05321602","title":"Study to Evaluate the PK Profiles of LY03010 in Patients With Schizophrenia or Schizoaffective Disorder","phase":"PHASE1","overall_status":"COMPLETED","enrollment_count":89,"lead_sponsor_name":"Luye Pharma Group Ltd.","has_results":false},{"nct_id":"NCT00693472","title":"Study of Preladenant for the Treatment of Neuroleptic Induced Akathisia (Study P05145)","phase":"PHASE2","overall_status":"TERMINATED","enrollment_count":46,"lead_sponsor_name":"Merck Sharp & Dohme LLC","has_results":true},{"nct_id":"NCT04898270","title":"Adjunctive Use of Fute (Flupentixol) in Multi-acting Receptor-targeted Antipsychotics Treated Schizophrenia Patients","phase":"PHASE4","overall_status":"COMPLETED","enrollment_count":30,"lead_sponsor_name":"Taichung Veterans General Hospital","has_results":false},{"nct_id":"NCT03287778","title":"Randomized Controlled Trial of Pyridoxine for Tardive Dyskinesia","phase":"NA","overall_status":"COMPLETED","enrollment_count":17,"lead_sponsor_name":"University of North Carolina, Chapel Hill","has_results":false}],"total":7},"guidelines":[],"source":"Drug Landscape verified database"}